首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1578307

全球抗凝血劑市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Anticoagulant Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計全球抗凝血劑市場需求將從2023年的401億美元增加至2032年的近899.5億美元，2024-2032年研究期間複合年成長率為9.39%。

抗凝血劑，通常稱為血液稀釋劑，是阻止或減少血液凝固並延長凝血時間的化學物質。抗凝血劑用於消除體內血栓的機會。當血小板黏合在一起並且血液中存在的蛋白質結合在一起形成固體塊時，就會形成血栓。抗凝血劑阻止血小板相互結合並阻止凝血蛋白黏附在一起。市面上提供各種類型的抗凝血藥物，每種藥物都透過阻止各種血液凝固途徑發揮作用。這些藥物主要用於治療高危險血栓、深部靜脈栓塞、肺栓塞等。此外，它們也常用於治療肺栓塞、心房顫動和控制中風風險。

市場動態

隨著全球靜脈血栓栓塞和心血管疾病等疾病的增加，全球抗凝血劑市場預計在未來幾年將大幅成長。此外，新型口服抗凝血劑的日益採用以及對新技術的認知的成熟正在推動市場成長。同樣，隨著對現代治療方法的需求不斷成長，肥胖問題和老年人口的擴大預計將影響預測期內全球抗凝血藥物市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球抗凝血劑市場的每個細分市場進行了包容性評估。抗凝血產業的成長和趨勢為本研究提供了整體方法。

市場區隔

抗凝血劑市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按藥品類別

新型口服抗凝血劑 (NOAC)（Eliquis、Xarelto、Savaysa & Lixiana、Pradaxa）
維生素K拮抗劑
直接凝血酶抑制劑
肝素和低分子肝素 (LMWH)
其他

依給藥途徑

口服抗凝血劑
注射抗凝血劑

按申請

心房顫動/心肌梗塞（心臟病發作）
深部靜脈血栓 (DVT)
肺栓塞
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲抗凝血劑市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。抗凝血劑市場的主要參與者包括阿斯彭控股公司、輝瑞公司、百時美施貴寶公司、葛蘭素史克公司、賽諾菲公司、拜耳公司、勃林格殷格翰國際有限公司、第一三共有限公司、強生服務公司、衛材有限公司本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：抗凝血劑公司的競爭格局

抗凝血藥市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Aspen Holdings

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Bristol-Myers Squibb Company

公司概況
公司收入
產品
最新動態

GSK Plc

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Bayer AG

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim International GmbH

公司概況
公司收入
產品
最新動態

Daiichi Sankyo Company Limited

公司概況
公司收入
產品
最新動態

Johnson & Johnson Services Inc.

公司概況
公司收入
產品
最新動態

Eisai Co. Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11211613

The global demand for Anticoagulant Market is presumed to reach the market size of nearly USD 89.95 Billion by 2032 from USD 40.1 Billion in 2023 with a CAGR of 9.39% under the study period 2024-2032.

Anticoagulants, generally called blood thinners, are chemical materials that prohibit or curtail coagulation of blood and lengthen the clotting period. Anticoagulants are used to abolish the chances of blood clots in the body. Blood clots are built when platelets glue together and proteins present in the blood bind together to create a solid lump. Anticoagulants cease the platelets from binding to one another and clotting proteins from adhering together. The market offers various types of anticoagulant drugs, and each drug functions by deterring various paths of blood coagulation. These drugs are primarily used for the high threat of blood clots, deep vein thrombosis, pulmonary embolism, and others. Besides, they are commonly used in the treatment of pulmonary embolism, atrial fibrillation, and managing the risk of stroke.

MARKET DYNAMICS

The global anticoagulants market is anticipated to grow at a substantial rate in the coming years, with the increasing plurality of diseases such as venous thromboembolism and cardiovascular disease across the globe. Moreover, the growing adoption of new oral anticoagulants, and maturing awareness of new techniques is boosting the market growth. Similarly, expanding obesity problems and geriatric population with the growing demand for contemporary therapeutics are predicted to affect the growth of the global anticoagulant market during the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Anticoagulant. The growth and trends of Anticoagulant industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Anticoagulant market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Category

Novel Oral Anticoagulants (NOACs) (Eliquis, Xarelto, Savaysa & Lixiana, Pradaxa)
Vitamin K Antagonist
Direct Thrombin Inhibitors
Heparin and Low Molecular Weight Heparin (LMWH)
Others

By Route of Administration

Oral Anticoagulants
Injectable Anticoagulants

By Application

Atrial Fibrillation/Myocardial Infarction (Heart Attack)
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Anticoagulant market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Anticoagulant market include Aspen Holdings, Pfizer Inc., Bristol-Myers Squibb Company, GSK Plc, Sanofi, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Eisai Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANTICOAGULANT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Category
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTICOAGULANT MARKET ANALYSIS BY DRUG CATEGORY

5.1. Overview By Drug Category
5.2. Historical and Forecast Data
5.3. Analysis By Drug Category
5.4. Novel Oral Anticoagulants (NOACs) (Eliquis, Xarelto, Savaysa & Lixiana, Pradaxa) Historic and Forecast Sales By Regions
5.5. Vitamin K Antagonist Historic and Forecast Sales By Regions
5.6. Direct Thrombin Inhibitors Historic and Forecast Sales By Regions
5.7. Heparin and Low Molecular Weight Heparin (LMWH) Historic and Forecast Sales By Regions
5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL ANTICOAGULANT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1. Overview By Route of Administration
6.2. Historical and Forecast Data
6.3. Analysis By Route of Administration
6.4. Oral Anticoagulants Historic and Forecast Sales By Regions
6.5. Injectable Anticoagulants Historic and Forecast Sales By Regions

7. GLOBAL ANTICOAGULANT MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data
7.3. Analysis By Application
7.4. Atrial Fibrillation/Myocardial Infarction (Heart Attack) Historic and Forecast Sales By Regions
7.5. Deep Vein Thrombosis (DVT) Historic and Forecast Sales By Regions
7.6. Pulmonary Embolism Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ANTICOAGULANT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ANTICOAGULANT COMPANIES

9.1. Anticoagulant Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ANTICOAGULANT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Aspen Holdings
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Pfizer Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Bristol-Myers Squibb Company
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. GSK Plc
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Sanofi
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Bayer AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Boehringer Ingelheim International GmbH
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Daiichi Sankyo Company Limited
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Johnson & Johnson Services Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Eisai Co. Ltd
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Drug Category (USD MN)
Novel Oral Anticoagulants (NOACs) (Eliquis, Xarelto, Savaysa & Lixiana, Pradaxa) Market Sales By Geography (USD MN)
Vitamin K Antagonist Market Sales By Geography (USD MN)
Direct Thrombin Inhibitors Market Sales By Geography (USD MN)
Heparin and Low Molecular Weight Heparin (LMWH) Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Route of Administration (USD MN)
Oral Anticoagulants Market Sales By Geography (USD MN)
Injectable Anticoagulants Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Atrial Fibrillation/Myocardial Infarction (Heart Attack) Market Sales By Geography (USD MN)
Deep Vein Thrombosis (DVT) Market Sales By Geography (USD MN)
Pulmonary Embolism Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Anticoagulant Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Anticoagulant Report
Market Research Process
Market Research Methodology
Global Anticoagulant Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Drug Category
Market Attractiveness Analysis By Route of Administration
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Drug Category (USD MN)
Novel Oral Anticoagulants (NOACs) (Eliquis, Xarelto, Savaysa & Lixiana, Pradaxa) Market Sales By Geography (USD MN)
Vitamin K Antagonist Market Sales By Geography (USD MN)
Direct Thrombin Inhibitors Market Sales By Geography (USD MN)
Heparin and Low Molecular Weight Heparin (LMWH) Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Route of Administration (USD MN)
Oral Anticoagulants Market Sales By Geography (USD MN)
Injectable Anticoagulants Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Atrial Fibrillation/Myocardial Infarction (Heart Attack) Market Sales By Geography (USD MN)
Deep Vein Thrombosis (DVT) Market Sales By Geography (USD MN)
Pulmonary Embolism Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis